Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: John F. Dowd who wrote (5934)	10/13/1998 12:16:00 PM
From: Anthony Wong	Read Replies (1) \| Respond to of 9523

Viagra to Be Introduced in Italy This Week, Newspaper Reports Bloomberg News October 13, 1998, 4:12 a.m. ET Rome, Oct. 13 (Bloomberg) -- Italians will soon be able to purchase Pfizer Inc.'s impotence treatment drug Viagra, which is being sold in pharmacies in Milan as of today and will be available in the rest of the country on Thursday, Italian daily La Stampa reported. The ministry of health said the blue pill will cost up to 200,800 lire ($120) for the highest dosage of 100 milligrams, while a standard-dose 4-pill pack will cost 83,000 lire, adding that the pill can only be obtained with a non-renewable doctor's prescription allowing the purchase of a maximum of 16 pills, the paper reported. According to La Stampa, some three million Italians suffer from impotence. In mid-September, the European Commission, the executive branch of the European Union, approved the sale and marketing of Viagra in the 15-nation bloc. (La Stampa, 10/13, p. 13) (www.lastampa.it) --Rosanna Maietta in the Rome bureau (3906) 6786 455 with Farah

To: John F. Dowd who wrote (5934)	10/13/1998 12:54:00 PM
From: Anthony Wong	Read Replies (1) \| Respond to of 9523

The AHP/MTC merger breakdown helps PFE, according to a Bloomberg article: Helps Pfizer, Merck The end of the merger helps Pfizer Inc. and Merck & Co., Keeney [analyst with ABN Amro] said. Goldman, Sachs & Co. advised Monsanto, and Bear Stearns & Co. advised American Home. Monsanto earlier this year entered an agreement with rival drugmaker Pfizer Inc., the maker of the impotence pill Viagra, to help market its new arthritis painkiller. Monsanto is expected to file this year with U.S. regulators for approval of the drug, potentially its biggest seller.